PURPOSE: The purpose of this study was to investigate the effect of locally delivered pancreatic islet with liposomal clodronate (Clodrosome®) as an immunoprotection agent for the treatment of type 1 diabetes. METHOD: The bio-distribution of liposomal clodronate in matrigel was checked by imaging analyzer. To verify the therapeutic efficacy of locally delivered islet with liposomal clodronate using injectable hydrogel, four groups of islet transplanted mice (n = 6 in each group) were prepared: 1) the islet group, 2) the islet-Clodrosome group, 3) the islet-Matrigel group, and 4) the islet-Matrigel-Clodrosome group. Immune cell migration and activation, and pro-inflammatory cytokine secretion was evaluated by immunohistochemistry staining and ELISA assay. RESULTS: Cy5.5 labeled liposomes remained in the matrigel for over 7 days. The median survival time of transplanted islets (Islet-Matrigel-Clodrosome group) was significantly increased (>60 days), compared to other groups. Locally delivered liposomal clodronate in matrigel effectively inhibited the activation of macrophages, immune cell migration and activation, and pro-inflammatory cytokine secretion from macrophages. CONCLUSIONS: Locally co-delivered pancreatic islets and liposomal clodronate using injectable hydrogel effectively cured type 1 diabetes. Especially, the inhibition of macrophage attack in the early stage after local delivery of islets was very important for the successful long-term survival of delivered islets.
PURPOSE: The purpose of this study was to investigate the effect of locally delivered pancreatic islet with liposomal clodronate (Clodrosome®) as an immunoprotection agent for the treatment of type 1 diabetes. METHOD: The bio-distribution of liposomal clodronate in matrigel was checked by imaging analyzer. To verify the therapeutic efficacy of locally delivered islet with liposomal clodronate using injectable hydrogel, four groups of islet transplanted mice (n = 6 in each group) were prepared: 1) the islet group, 2) the islet-Clodrosome group, 3) the islet-Matrigel group, and 4) the islet-Matrigel-Clodrosome group. Immune cell migration and activation, and pro-inflammatory cytokine secretion was evaluated by immunohistochemistry staining and ELISA assay. RESULTS:Cy5.5 labeled liposomes remained in the matrigel for over 7 days. The median survival time of transplanted islets (Islet-Matrigel-Clodrosome group) was significantly increased (>60 days), compared to other groups. Locally delivered liposomal clodronate in matrigel effectively inhibited the activation of macrophages, immune cell migration and activation, and pro-inflammatory cytokine secretion from macrophages. CONCLUSIONS: Locally co-delivered pancreatic islets and liposomal clodronate using injectable hydrogel effectively cured type 1 diabetes. Especially, the inhibition of macrophage attack in the early stage after local delivery of islets was very important for the successful long-term survival of delivered islets.
Authors: Barbara J Olack; Andrés Jaramillo; Nicholas D Benshoff; Zahid Kaleem; Carol J Swanson; Jeffrey A Lowell; T Mohanakumar Journal: Xenotransplantation Date: 2002-11 Impact factor: 3.907
Authors: A M James Shapiro; Camillo Ricordi; Bernhard J Hering; Hugh Auchincloss; Robert Lindblad; R Paul Robertson; Antonio Secchi; Mathias D Brendel; Thierry Berney; Daniel C Brennan; Enrico Cagliero; Rodolfo Alejandro; Edmond A Ryan; Barbara DiMercurio; Philippe Morel; Kenneth S Polonsky; Jo-Anna Reems; Reinhard G Bretzel; Federico Bertuzzi; Tatiana Froud; Raja Kandaswamy; David E R Sutherland; George Eisenbarth; Miriam Segal; Jutta Preiksaitis; Gregory S Korbutt; Franca B Barton; Lisa Viviano; Vicki Seyfert-Margolis; Jeffrey Bluestone; Jonathan R T Lakey Journal: N Engl J Med Date: 2006-09-28 Impact factor: 91.245
Authors: Hannu Mönkkönen; Soili Törmälehto; Kari Asunmaa; Riku Niemi; Seppo Auriola; Jouko Vepsäläinen; Jukka Mönkkönen Journal: Eur J Pharm Sci Date: 2003-05 Impact factor: 4.384
Authors: Tanja P A M Slegers; Ruth van der Gaag; Nico van Rooijen; Gabriel van Rij; J Wayne Streilein Journal: Curr Eye Res Date: 2003-02 Impact factor: 2.424
Authors: Louise Elander; Linda Engström; Johan Ruud; Ludmila Mackerlova; Per-Johan Jakobsson; David Engblom; Camilla Nilsberth; Anders Blomqvist Journal: J Neurosci Date: 2009-02-04 Impact factor: 6.167
Authors: Simone Capuani; Nathanael Hernandez; Jesus Paez-Mayorga; Prashant Dogra; Zhihui Wang; Vittorio Cristini; Corrine Ying Xuan Chua; Joan E Nichols; Alessandro Grattoni Journal: Mater Today Bio Date: 2022-08-11
Authors: Xi Wang; Natalie K Brown; Bo Wang; Kaavian Shariati; Kai Wang; Stephanie Fuchs; Juan M Melero-Martin; Minglin Ma Journal: Adv Sci (Weinh) Date: 2021-07-14 Impact factor: 16.806